Literature DB >> 12463160

Proteolytic processing of the amyloid-beta protein precursor of Alzheimer's disease.

Janelle Nunan1, David H Small.   

Abstract

The proteolytic processing of the amyloid-beta protein precursor plays a key role in the development of Alzheimer's disease. Cleavage of the amyloid-beta protein precursor may occur via two pathways, both of which involve the action of proteases called secretases. One pathway, involving beta- and gamma-secretase, liberates amyloid-beta protein, a protein associated with the neurodegeneration seen in Alzheimer's disease. The alternative pathway, involving alpha-secretase, precludes amyloid-beta protein formation. In this review, we describe the progress that has been made in identifying the secretases and their potential as therapeutic targets in the treatment or prevention of Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12463160     DOI: 10.1042/bse0380037

Source DB:  PubMed          Journal:  Essays Biochem        ISSN: 0071-1365            Impact factor:   8.000


  11 in total

Review 1.  Neuronutrition and Alzheimer's disease.

Authors:  Balenahalli N Ramesh; T S Sathyanarayana Rao; Annamalai Prakasam; Kumar Sambamurti; K S Jagannatha Rao
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

2.  A pilot proteomic study of amyloid precursor interactors in Alzheimer's disease.

Authors:  Barbara A Cottrell; Veronica Galvan; Surita Banwait; Olivia Gorostiza; Christian R Lombardo; Tristan Williams; Birgit Schilling; Alyson Peel; Bradford Gibson; Edward H Koo; Christopher D Link; Dale E Bredesen
Journal:  Ann Neurol       Date:  2005-08       Impact factor: 10.422

3.  Three-dimensional quantitative structure-activity relationship (3D-QSAR) studies of various benzodiazepine analogues of gamma-secretase inhibitors.

Authors:  Tarnvir Sammi; Om Silakari; Muttineni Ravikumar
Journal:  J Mol Model       Date:  2008-12-06       Impact factor: 1.810

Review 4.  Surface plasmon resonance for the analysis of beta-amyloid interactions and fibril formation in Alzheimer's disease research.

Authors:  Marie-Isabel Aguilar; David H Small
Journal:  Neurotox Res       Date:  2005       Impact factor: 3.911

Review 5.  Pin1 in Alzheimer's disease: multiple substrates, one regulatory mechanism?

Authors:  Martin Balastik; Jormay Lim; Lucia Pastorino; Kun Ping Lu
Journal:  Biochim Biophys Acta       Date:  2007-01-23

6.  Interaction of ASK1 and the beta-amyloid precursor protein in a stress-signaling complex.

Authors:  Veronica Galvan; Surita Banwait; Patricia Spilman; Olivia F Gorostiza; Alyson Peel; Marina Ataie; Danielle Crippen; Wei Huang; Gurleen Sidhu; Hidenori Ichijo; Dale E Bredesen
Journal:  Neurobiol Dis       Date:  2007-07-03       Impact factor: 5.996

7.  Evaluation of BACE1 Silencing in Cellular Models.

Authors:  Malgorzata Sierant; Katarzyna Kubiak; Julia Kazmierczak-Baranska; Masaki Warashina; Tomoko Kuwabara; Barbara Nawrot
Journal:  Int J Alzheimers Dis       Date:  2009-07-14

8.  Inhibition of death-associated protein kinase 1 attenuates the phosphorylation and amyloidogenic processing of amyloid precursor protein.

Authors:  Byeong Mo Kim; Mi-Hyeon You; Chun-Hau Chen; Jaehong Suh; Rudolph E Tanzi; Tae Ho Lee
Journal:  Hum Mol Genet       Date:  2016-04-19       Impact factor: 6.150

9.  Cerebral arachidonate cascade in dementia: Alzheimer's disease and vascular dementia.

Authors:  Tatsurou Yagami
Journal:  Curr Neuropharmacol       Date:  2006-01       Impact factor: 7.363

10.  Mitochondrial respiratory inhibition and oxidative stress elevate beta-secretase (BACE1) proteins and activity in vivo in the rat retina.

Authors:  Kun Xiong; Huaibin Cai; Xue-Gang Luo; Robert G Struble; Richard W Clough; Xiao-Xin Yan
Journal:  Exp Brain Res       Date:  2007-04-12       Impact factor: 1.972

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.